【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the Protein Kinase Inhibitor Market for Cancer Treatments, 2015
1.2 Benefits of This Report
1.2.1 How This Report Delivers
1.2.2 Main Questions Answered by this Analytical Study
1.3 Who is This Report For?
1.4 Methods of the Study
1.5 Frequently Asked Questions (FAQ)
1.6 Associated Visiongain Reports
1.7 About Visiongain
2. Introduction to Anti-Cancer Kinase Inhibitors
2.1 What are Protein Kinases and Protein Kinase Inhibitors?
2.2 Protein Kinases in Oncology
2.3 Glossary
3. Leading Anti-Cancer Kinase Inhibitor Drugs: Forecasts and Discussions, 2015-2025
3.1 Brc-Abl Inhibitors – Transforming Chronic Myeloid Leukaemia from a Fatal Diagnosis To a Managed Lifestyle
3.1.1 Glivec/Gleevec (imatinib) – Novartis
3.1.2 Sprycel (dasatinib) – Bristol-Myers Squibb
3.1.3 Tasigna (nilotinib) – Novartis
3.1.4 Bosulif (bosutinib) – Pfizer
3.1.5 Iclusig (ponatinib) – ARIAD Pharmaceuticals
3.2 EGFR Inhibitors Target a Mutation-Positive Market
3.2.1 Tarceva (erlotinib) – Roche/Astellas
3.2.2 Iressa (gefinitib) – AstraZeneca
3.2.3 Gilotrif/Giotrif (afatinib) – Boehringer Ingelheim
3.3 Angiogenesis Inhibitors Have a Variety of Indications
3.3.1 Nexavar (sorafenib) – Bayer/Onyx
3.3.2 Sutent (sunitinib) – Pfizer
3.3.3 Votrient (pazopanib) – Novartis
3.3.4 Inlyta (axitinib) – Pfizer
3.4 BRAF and MEK Inhibitors: A Promising Combination
3.4.1 Zelboraf (vemurafenib) – Roche
3.4.2 Mekinist (trametinib) and Tafinlar (dabrafenib) – Novartis
3.5 mTOR Inhibitors Have a New Entrant
3.5.1 Afinitor/Votubia (everolimus) – Novartis
3.5.2 Torisel (temsirolimus) – Pfizer
3.5.3 Zydelig (idelalisib) – Gilead Sciences
3.6 Other Leading Cancer Inhibitors Are a Varied Group
3.6.1 Imbruvica (ibrutinib) – J&J/Pharmacyclics/AbbVie
3.6.2 Jakavi/Jakafi (ruxolitinib) – Novartis/Incyte
3.6.3 Xalkori (crizotinib) – Pfizer
3.6.4 Cometriq (cabozantinib) – Exelixis
3.6.5 Caprelsa (vandetanib) – AstraZeneca
3.6.6 Tyverb/Tykerb (lapatinib) – Novartis
3.6.7 Stivarga (regorafenib) – Bayer
3.6.8 Zykadia (ceritinib, LDK378) – Novartis
3.6.9 Ibrance (palbociclib) – Pfizer
3.6.10 Alectinib (AF802) – Roche
4. Anti-Cancer Kinase Inhibitors: World Market Outlook and Forecast, 2015-2025
4.1 Global Anti-Cancer Kinase Inhibitors Market: Leading Kinase Inhibitors in 2014
4.2 World Anti-Cancer Kinase Inhibitors Market: Revenue Forecasts and Change in Market Shares by Class 2015-2025
4.3 Bcr-Abl Inhibitors Lead the Anti-Cancer Kinase Inhibitors Market in 2015
4.3.1 Drivers and Restraints of the Bcr-Abl Kinase Inhibitors Market 2015-2025
4.4 Novel Kinase Inhibitors Will Dominate the Market As They Cover a Broad Range
4.4.1 Drivers and Restraints of these Other Kinase Inhibitors 2015-2025
5. Leading National Markets for Anti-Cancer Kinase Inhibitors, 2015-2025
5.1 Regional Breakdown of the Global Anti-Cancer Kinase Inhibitors Market, 2014
5.2 World Anti-Cancer Kinase Inhibitors Market: Regional Forecast 2015-2025
5.3 How Will Regional Market Shares Change through to 2025?
5.4 The US Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.4.1 Drivers and Restraints of the US Anti-Cancer Kinase Inhibitors Market 2015-2025
5.5 The EU Anti-Cancer Kinase Inhibitors Market 2015-2025
5.5.1 Drivers and Restraints of the EU Anti-Cancer Kinase Inhibitors Market 2015-2025
5.5.2 German Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.3 French Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.4 Italian Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.5 UK Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.5.6 Spanish Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.6 Japanese Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7 The Anti-Cancer Kinase Inhibitors Emerging Market: BRIC 2015-2025
5.7.1 China: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7.2 India: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7.3 Brazil: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
5.7.4 Russia: Anti-Cancer Kinase Inhibitors Market Forecast 2015-2025
6. Anti-Cancer Kinase Inhibitors: R&D Pipeline, 2015
6.1 Cyclin-Dependent Kinase 4/6 Inhibitors in Development
6.1.1 LEE-011 – Novartis
6.1.2 Abemaciclib (LY2835219) – Eli Lilly
6.2 ALK Inhibitors in Development
6.2.1 Brigatinib (AP26113) – ARIAD Pharmaceuticals
6.3 Bruton’s Tyrosine Kinase and PI3K Inhibitors in Development
6.3.1 Venetoclax (ABT-199/RG7601/GDC-0199)– Roche/AbbVie
6.3.2 Duvelisib (IPI-145) – Infinity Pharmaceuticals/AbbVie
6.3.3 Buparlisib (BKM120) – Novartis
6.3.4 ONO-4059 – ONO Pharmaceutical/Gilead Sciences
6.3.5 Copanlisib (BAY 80-6946) – Bayer
6.3.6 Pictilisib (GDC-0941/RG7321) – Roche
6.3.7 BEZ235 – Novartis
6.4 MEK and BRAF Inhibitors in Development
6.4.1 Cobimetinib (GDC-0973/XL518) – Exelixis/Roche
6.4.2 Encorafenib (LGX818) & Binimetinib (MEK162)– Array BioPharma
6.4.3 Selumetinib (AZD 6244) – AstraZeneca/Array BioPharma
6.5 Other Anti-Cancer Kinase Inhibitors in Development
6.5.1 Volasertib – Boehringer Ingelheim
6.5.2 Neratinib (PB272) – Puma Biotechnology
6.5.3 Tivantinib (ARQ197) – Daiichi Sankyo/ArQule
6.5.4 Dovitinib (TKI258) – Novartis
6.5.5 Dacomitinib – Pfizer
6.5.6 Rociletinib (CO-1686) – Clovis Oncology
6.5.7 Entrectinib (RXDX-101) – Ignyta
6.5.8 INC280 and EGF816 – Novartis
7. Leading Companies in the Anti-Cancer Kinase Inhibitors Market, 2015
7.1 Leading Companies in the Anti-Cancer Kinase Inhibitors Market by Revenue, 2014
7.1.1 Leading Anti-Cancer Kinase Inhibitors Manufacturers: Revenue Forecasts, 2015-2025
7.2 Leading Anti-Cancer Kinase Inhibitor Company Profiles
7.2.1 Novartis: Interesting Developments and a Continued Lead on the Market
7.2.2 Pfizer: Advancing Closer to Novartis’ Lead
7.2.3 Roche: A Global Giant in Cancer Treatment
7.2.4 Bristol-Myers Squibb’s Success is Tied to Sprycel
7.2.5 Bayer Healthcare: Nexavar and Stivarga
7.2.6 AstraZeneca Needs the US Market To Succeed
7.2.7 Gilead Sciences
7.3 Other Companies
7.3.1 AbbVie
7.3.2 Boehringer Ingelheim BioXcellence
8. Qualitative Analysis of the Anti-Cancer Kinase Inhibitors Market, 2015-2025
8.1 SWOT Analysis of the Anti-Cancer Kinase Inhibitors Market
8.2 Strengths
8.2.1 Personalised Medicine is a Strong Trend in Cancer Treatment
8.2.2 Targeted Kinase Inhibitors are Generally Well-Tolerated
8.2.3 Strong Pipeline of Novel Inhibitors Will Drive Market Growth
8.2.4 Oral Dosage is the Preferred Treatment
8.3 Weaknesses
8.3.1 High-Cost of Treatment May Restrain the Market
8.3.2 Ease of Manufacturing Small Molecule Drugs
8.3.3 Monoclonal Antibodies are More Specific than Small Molecules
8.4 Opportunities
8.4.1 Ageing Populations and Rising Cancer Prevalence Will Increase Demand for Treatment
8.4.2 Investment into Research May Lead to Improved Targeted Treatments
8.4.3 Combination Therapies Bring Additive Benefits
8.5 Threats
8.5.1 Regulations: Can they Restrain the Market?
8.5.2 Multiple Companies Competing
8.6 STEP Analysis of the Anti-Cancer Kinase Inhibitors Market
9. Research Interviews
9.1 Interview with Dr Lawrence Bloch, Chief Finance and Business Officer, Infinity Pharmaceuticals, United States
9.1.1 Positioning a Novel Therapeutic in Blood Cancer Indications
9.1.2 Combining Therapies Offers Significant Benefit to Patients
9.1.3 Potential in Rheumatoid Arthritis and Blood Cancers
9.2 Interview with Dr Marcel Spaargaren, Associate Professor, LYMMCARE (Lymphoma and Myeloma Center Amsterdam)
9.2.1 Combining Two Kinase Inhibitor Therapeutics
9.2.2 Expectations for Kinase Inhibitor Therapies as Cancer Treatments
9.2.3 The Future of B-Cell Receptor Inhibitors
10. Conclusions from the Research and Analysis
10.1 World Anti-Cancer Kinase Inhibitors Market: Outlook from 2015
10.1.1 Recent Launches of Innovative Drugs and a Robust Pipeline Will Drive Market Growth
10.2 Opportunities in Developed and Developing National Pharma Markets Expanding Those Drug Sales
【レポート販売概要】
■ タイトル：がん治療用キナーゼ阻害剤の世界市場■ 英文：Kinase Inhibitors for Cancer Treatment: World Industry Analysis, R&D and Market Forecasts 2015-2025
: Explore the Potentials of New Drugs
■ 発行日：2015年8月
■ 調査会社：visiongain
■ 商品コード：VGAIN5081916
■ 調査対象地域：グローバル
- 直接メタノール燃料電池（DMFC）の世界市場予測（～2020）The Direct Methanol Fuel Cells (DMFC) market is expected to reach USD 188.82 Million by 2020, at a CAGR of 15.3% from 2015 to 2020. The growing demand for clean energy has been accompanied by depletion of fossil fuels, which has shifted the focus toward fuel cell markets. The DMFC market is still in its initial development phase in all the regions due to slow infrastructure development for refueli …
- アジア・北アフリカの救急救命装置市場：点滴ポンプ、人工呼吸器、患者モニターThe critical care devices market in emerging nations is expected to reach USD 2.61 Billion by 2021 from USD 1.78 Billion in 2016, growing at a CAGR of 8.0% between 2016 and 2021. On the basis of products, the critical care devices market is divided into three segments, namely, patient monitors, ventilators, and infusion pumps. The patient monitors segment is expected to grow at the highest CAGR in …
- スマートアドバイザーの世界市場予測（～2021年）The smart advisors market size is estimated to grow from USD 703.3 Million in 2016 and to USD 3,172.0 Million by 2021, at a CAGR of 35.2% from 2016 to 2021. Some of the major factors that are driving the growth of the market include the proliferating demand of intelligent customer engagement, increasing penetration of websites & mobile applications, and surge in demand of automated patient managem …
- 再生可能エネルギー産業2013Renewable Energy Industry in 2013: Expected Trends and Analysis Summary In recent years the global renewable industry has seen rapid growth backed by strong policy support. Globally, renewable energy total installed capacity grew from 374 Gigawatts (GW) in 2011 to 474 GW in 2012. It is expected that renewable energy installed capacity will reach 545 GW by the end of 2013. Wind is the most prominen …
- 世界のストレージ市場動向（2012-2016）TechNavio's analysts forecast the Global Storage market to grow at a CAGR of 7.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased growth of structured and unstructured data. The Global Storage market has also been witnessing a collaboration of storage software and hardware solutions. However, the increasing availability of open source s …
- クラウドサプライチェーン管理ソリューションの世界市場予測（～2021年）“Factors such as awareness about cloud-based supply chain management benefits among the enterprises and reduced operational & capital expenditure are driving the cloud Supply Chain Management (SCM) market” The cloud SCM market size is estimated to grow from 3.26 billion in 2016 to USD 8.07 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 19.8% during the forecast period. The market is d …
- アフェクティブコンピューティングの世界市場予測：タッチベース、タッチレスDeployment of emotion AI-related technologies in customer interaction solutions across retail and healthcare verticals and growing adoption of virtual assistants for healthcare and entertainment purposes are driving the overall growth of the affective computing market.The global affective computing market size is projected to grow from USD 22.2 billion in 2019 to USD 90.0 billion by 2024, at a CAG …
- 世界のホット飲料市場のM&A動向（2014年6月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global hot drinks market during June 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global hot drinks market throughout the month. Additionally, the report provides an overview of all the partn …
- 頻脈(頻脈性不整脈)(Tachycardia (Tachyarrhythmias))：世界の治験レビュー（2015年上半期版）Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2015" provides data on the Tachycardia (Tachyarrhythmias) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tachycardia (Tachyarrhythmias). It includes an o …
- デジタルX線装置の世界市場：インターベンショナルX線装置、マンモグラフィーX線装置、歯科用X線装置、汎用X線装置、動物用X線装置、モバイルCアームAbout Digital X-ray Systems Digital X-ray systems are used for diagnosing and treatment of diseases by creating and recording images. The X-ray images captured using a digital system are no different from that of screen-film radiography. In a digital system, screen-film detectors and sensors generate the digital image. Digital detectors allow full implementation of image archiving and communicatio …
- ブラジルの速達サービス市場About Express Delivery Market in Brazil Express delivery is the accelerated delivery of items that are non-palletized and weigh less than 110 pounds, such as parcels, documents, and letters, to different types of customers, such as business customers, retail customers, and government agencies. Express deliveries are usually made within two or three days, depending on customer requirements. These s …
- 対戦車ミサイル（ATM）システムの世界市場2016-2020About Anti-Tank Missile Systems The tactical anti-tank missile systems are generally of two types. Long-range anti-tank missiles are very capable weapon systems, which are used to destroy heavy armored vehicles. They rely on warheads to penetrate and damage the tanks or armored vehicles. Whereas the short-range anti-tank missiles are man-portable, and they pose a lesser threat to armored vehicles. …
- ハエ駆除用化学薬品の世界市場：種類別（殺幼虫剤＆殺ダニ剤）、廃棄物処理方法別（機械的生物学的処理、焼却、嫌気性消化）、適用方法別（毒性餌、ジクロロス気化器、屋外噴霧、殺幼虫剤噴霧器、その他）The fly control chemicals market for waste management accounted for $74.4 billion in 2018 and is anticipated to reach $120.9 billion by 2026, registering a CAGR of 6.1% from 2019 to 2026. Waste management is a systematic procedure of treating waste, comprising numerous activities such as collecting, transportation, and treatment (mechanical/ biological/ chemical). The growth of the market is drive …
- フェニールケトン尿症（Phenylketonuria）：グローバル臨床試験動向（2014年上半期）Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014" provides data on the Phenylketonuria (PKU) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Phenylketonuria (PKU). It includes an overview of the trial numbers and the …
- 世界のフッ素系界面活性剤市場2015The Global Fluorosurfactant Industry Report 2015 is a professional and in-depth study on the current state of the Fluorosurfactant industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Fluorosurfactant market analysis is provided for the international markets including development trends, competitive lan …
